Evidence map›Paper›PMID 33055476›Full record

ArticleInternal medicine (Tokyo, Japan)2021

Short-term Changes in Self-rating Depression Scale Scores after Smoking Cessation in Neurotic Patients.

Maki Komiyama, Yuka Ozaki, Yusuke Miyazaki, Akihiro Yasoda, Hiromichi Wada, Hajime Yamakage, Noriko Satoh-Asahara, Tatsuya Morimoto, Akira Shimatsu, Yuko Takahashi and 1 more

Abstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maki KomiyamaClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Yuka OzakiClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Yusuke MiyazakiDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan.
Akihiro YasodaClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Hiromichi WadaClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Hajime YamakageClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Noriko Satoh-AsaharaClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Tatsuya MorimotoDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan.
Akira ShimatsuClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Yuko TakahashiClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.
Koji HasegawaClinical Research Institute, National Hospital Organization Kyoto Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The psychological status is a key factor in smoking continuance. However, details on short-term changes in mild depressive states after smoking cessation (SC) are still unknown. The purpose of the present study was to investigate these short-term changes. Methods A total of 989 patients who visited our SC Clinic were assessed using the Zung Self-Rating-Depression-Scale (SDS), an official instrument to measure depressive tendencies. The participants were classified into normal and neurotic groups based on their SDS scores during their initial visit; they were assessed again 2, 4, 8, and 12 weeks thereafter. Results The majority of patients in the neurotic group were women. These patients were also younger, with a higher nicotine dependence, and presented with a lower successful SC rate than the patients in the normal group. A decrease in SDS scores after starting the SC treatment was observed only in the neurotic group, especially during the first two weeks. In patients who continued to smoke, no improvement in depressive tendencies was noted in this period. Conclusion Depressive tendencies of patients with neurosis improve in the initial stages of the SC treatment (i.e., within two weeks after starting the treatment). This finding fills the mentioned knowledge gap regarding the effects of SC on mild depressive states in the short term.

Indexed as

Depressive DisorderSmoking CessationTobacco Use DisorderDepressionFemaleHumansSmokingdepressionnicotine dependencesmokingsmoking cessation

Identifiers

PMID33055476
PMCPMC8112982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.